Page last updated: 2024-10-27

foscarnet and Arthritis, Juvenile

foscarnet has been researched along with Arthritis, Juvenile in 1 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Arthritis, Juvenile: Arthritis in children, with onset before 16 years of age. The terms juvenile rheumatoid arthritis (JRA) and juvenile idiopathic arthritis (JIA) refer to classification systems for chronic arthritis in children. Only one subtype of juvenile arthritis (polyarticular-onset, rheumatoid factor-positive) clinically resembles adult rheumatoid arthritis and is considered its childhood equivalent.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wong, KJ1
Osowicki, J1
Seaby, E1
Curtis, N1
Gwee, A1

Other Studies

1 other study available for foscarnet and Arthritis, Juvenile

ArticleYear
Bullous herpes zoster.
    The Journal of pediatrics, 2014, Volume: 164, Issue:3

    Topics: Adolescent; Anti-Bacterial Agents; Antiviral Agents; Arthritis, Juvenile; Female; Floxacillin; Fosca

2014